BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L. Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Front Pharmacol 2021;12:623985. [PMID: 33995022 DOI: 10.3389/fphar.2021.623985] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Nikolaidis A, Lancelotta R, Gukasyan N, Griffiths RR, Barrett FS, Davis AK. Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms. J Affect Disord 2023;324:239-49. [PMID: 36584715 DOI: 10.1016/j.jad.2022.12.042] [Reference Citation Analysis]
2 Apud I. Ayahuasca and personality. A systematic review and meta-analysis of cross-sectional studies with long-term participants (Ayahuasca y personalidad. Revisión sistemática y metaanálisis de estudios transversales con participantes de larga trayectoria). Studies in Psychology 2023. [DOI: 10.1080/02109395.2022.2163776] [Reference Citation Analysis]
3 Beaussant Y, Nigam K. Expending Perspectives on the Potential for Psychedelic-Assisted Therapies to Improve the Experience of Aging. Am J Geriatr Psychiatry 2023;31:54-7. [PMID: 36307304 DOI: 10.1016/j.jagp.2022.09.017] [Reference Citation Analysis]
4 Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL. Body mass index (BMI) does not predict responses to psilocybin. J Psychopharmacol 2023;37:107-16. [PMID: 36373934 DOI: 10.1177/02698811221131994] [Reference Citation Analysis]
5 Bohn A, Kiggen MHH, Uthaug MV, van Oorsouw KIM, Ramaekers JG, van Schie HT. Altered States of Consciousness During Ceremonial San Pedro Use. The International Journal for the Psychology of Religion 2022. [DOI: 10.1080/10508619.2022.2139502] [Reference Citation Analysis]
6 Tvorun-Dunn M. Acid liberalism: Silicon Valley's enlightened technocrats, and the legalization of psychedelics. Int J Drug Policy 2022;110:103890. [PMID: 36279734 DOI: 10.1016/j.drugpo.2022.103890] [Reference Citation Analysis]
7 Hartogsohn I, Petranker R. Set and setting in microdosing: an oft-overlooked principle. Psychopharmacology 2022. [DOI: 10.1007/s00213-022-06249-8] [Reference Citation Analysis]
8 Dourron HM, Strauss C, Hendricks PS, Barker E. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Pharmacol Rev 2022;74:982-1027. [DOI: 10.1124/pharmrev.121.000514] [Reference Citation Analysis]
9 Pizarro JJ, Zumeta LN, Bouchat P, Włodarczyk A, Rimé B, Basabe N, Amutio A, Páez D. Emotional processes, collective behavior, and social movements: A meta-analytic review of collective effervescence outcomes during collective gatherings and demonstrations. Front Psychol 2022;13:974683. [DOI: 10.3389/fpsyg.2022.974683] [Reference Citation Analysis]
10 Engel LB, Thal SB, Bright SJ. Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior: Can “Trip Sitters” Help Inform Psychedelic Harm Reduction Services? Contemporary Drug Problems 2022. [DOI: 10.1177/00914509221121420] [Reference Citation Analysis]
11 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Psychopharmacology (Berl) 2022. [PMID: 35939083 DOI: 10.1007/s00213-022-06187-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bathje GJ, Majeski E, Kudowor M. Psychedelic integration: An analysis of the concept and its practice. Front Psychol 2022;13:824077. [DOI: 10.3389/fpsyg.2022.824077] [Reference Citation Analysis]
13 Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. J Psychopharmacol 2022;36:932-42. [PMID: 35924888 DOI: 10.1177/02698811221101061] [Reference Citation Analysis]
14 Roseman L, Preller KH, Fotiou E, Winkelman MJ. Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives. Front Pharmacol 2022;13:979764. [DOI: 10.3389/fphar.2022.979764] [Reference Citation Analysis]
15 van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neurosci Biobehav Rev 2022;140:104793. [PMID: 35878791 DOI: 10.1016/j.neubiorev.2022.104793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pontual AADD, Tófoli LF, Corradi-webster CM, van Oorsouw K, Delgado ARO, Ramaekers JG. The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users. Front Psychol 2022;13:857372. [DOI: 10.3389/fpsyg.2022.857372] [Reference Citation Analysis]
17 Bonnelle V, Smith WJ, Mason NL, Cavarra M, Kryskow P, Kuypers KP, Ramaekers JG, Feilding A. Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey. British Journal of Pain. [DOI: 10.1177/20494637221114962] [Reference Citation Analysis]
18 Hartogsohn I. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture. Transcult Psychiatry 2022;:13634615221100385. [PMID: 35818775 DOI: 10.1177/13634615221100385] [Reference Citation Analysis]
19 Brennan W, Belser AB. Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Front Psychol 2022;13:866018. [PMID: 35719571 DOI: 10.3389/fpsyg.2022.866018] [Reference Citation Analysis]
20 Glowacki DR, Williams RR, Wonnacott MD, Maynard OM, Freire R, Pike JE, Chatziapostolou M. Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-12637-z] [Reference Citation Analysis]
21 Apud I, Scuro J, Carrera I, Oliveri A. Ayahuasca Ritual, Personality and Sociality. Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay. J Psychoactive Drugs 2022;:1-10. [PMID: 35506737 DOI: 10.1080/02791072.2022.2053004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report. Front Pharmacol 2022;13:841648. [PMID: 35355714 DOI: 10.3389/fphar.2022.841648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-beiner A, Baker-jones M, Nutt D, Erritzoe D, Watts R, Carhart-harris R. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Front Pharmacol 2022;12:788155. [DOI: 10.3389/fphar.2021.788155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
24 Bălăet̨ M. Psychedelic Cognition—The Unreached Frontier of Psychedelic Science. Front Neurosci 2022;16:832375. [DOI: 10.3389/fnins.2022.832375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Agin-liebes G, Zeifman R, Luoma JB, Garland EL, Campbell WK, Weiss B. Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. J Psychopharmacol 2022;36:295-308. [DOI: 10.1177/02698811221080165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility. J Psychopharmacol 2022;36:387-408. [DOI: 10.1177/02698811211073758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sekula AD, Downey L, Puspanathan P. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Front Psychol 2022;13:813746. [DOI: 10.3389/fpsyg.2022.813746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Dupuis D. The psychedelic ritual as a technique of the self. HAU: Journal of Ethnographic Theory 2022;12:198-216. [DOI: 10.1086/719792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Vaid G, Walker B. Psychedelic Psychotherapy: Building Wholeness Through Connection. Glob Adv Health Med 2022;11:2164957X221081113. [PMID: 35223197 DOI: 10.1177/2164957X221081113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 St. Arnaud KO, Sharpe D. Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users. Journal of Psychoactive Drugs. [DOI: 10.1080/02791072.2022.2039815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ. Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. J Psychopharmacol 2022;:2698811211069100. [PMID: 35107059 DOI: 10.1177/02698811211069100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
32 Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry 2021;12:800072. [PMID: 34975593 DOI: 10.3389/fpsyt.2021.800072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
33 Golden TL, Magsamen S, Sandu CC, Lin S, Roebuck GM, Shi KM, Barrett FS. Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature. Disruptive Psychopharmacology 2022. [DOI: 10.1007/7854_2021_298] [Reference Citation Analysis]
34 Whitfield HJ. A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. Front Psychiatry 2021;12:727572. [PMID: 34950063 DOI: 10.3389/fpsyt.2021.727572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Weiss B, Nygart V, Pommerencke LM, Carhart-Harris RL, Erritzoe D. Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality. Front Psychol 2021;12:749788. [PMID: 34899488 DOI: 10.3389/fpsyg.2021.749788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Dupuis D. Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens. Front Psychol 2021;12:730031. [PMID: 34887799 DOI: 10.3389/fpsyg.2021.730031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
37 St. Arnaud KO. Toward a positive psychology of psychoactive drug use. Drugs: Education, Prevention and Policy 2021. [DOI: 10.1080/09687637.2021.2002816] [Reference Citation Analysis]
38 Timmermann C, Kettner H, Letheby C, Roseman L, Rosas FE, Carhart-Harris RL. Psychedelics alter metaphysical beliefs. Sci Rep 2021;11:22166. [PMID: 34815421 DOI: 10.1038/s41598-021-01209-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
39 Rodríguez Arce JM, Winkelman MJ. Psychedelics, Sociality, and Human Evolution. Front Psychol 2021;12:729425. [PMID: 34659037 DOI: 10.3389/fpsyg.2021.729425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Newson M, Khurana R, Cazorla F, van Mulukom V. 'I Get High With a Little Help From My Friends' - How Raves Can Invoke Identity Fusion and Lasting Co-operation via Transformative Experiences. Front Psychol 2021;12:719596. [PMID: 34646208 DOI: 10.3389/fpsyg.2021.719596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Pontual AAD, Tófoli LF, Collares CF, Ramaekers JG, Corradi-Webster CM. The Setting Questionnaire for the Ayahuasca Experience: Questionnaire Development and Internal Structure. Front Psychol 2021;12:679016. [PMID: 34248778 DOI: 10.3389/fpsyg.2021.679016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Roseman L, Ron Y, Saca A, Ginsberg N, Luan L, Karkabi N, Doblin R, Carhart-Harris R. Relational Processes in Ayahuasca Groups of Palestinians and Israelis. Front Pharmacol 2021;12:607529. [PMID: 34093170 DOI: 10.3389/fphar.2021.607529] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]